Product Code: GVR-1-68038-729-2
Folic Acid Market Growth & Trends:
The global folic acid market size is expected to reach USD 1.40 billion by 2030, registering a CAGR of 5.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing consumption of vitamin B9 as a source of an essential supplement during pregnancy by women that minimizes the risk of congenital disabilities in infants is anticipated to augment the market demand in the coming years.
Folic acid is required for the metabolism of specific biochemical reactions and cell division in the body. It plays a significant role in the development of the nervous system in the growing fetus. Moreover, it is involved in the formation of red blood cells, supporting the normal development of the neural tube in the fetus. Market drivers include the increasing demand from pharmaceutical and nutraceuticals industry for manufacturing instant folate-rich food products owing to its health benefits.
Improved medical facilities, increasing disposable income and adoption of social programs by the government to encourage healthcare initiatives have led to growing demand folic acid products. Pharmaceuticals dominated the market in 2015, followed by nutraceuticals. Asia Pacific dominated the folic acid market in 2015 due to the high production of the raw material in emerging economies such as China, which is a primary manufacturer of the vitamins globally.
Companies such as BASF SE, Zydus Pharmaceuticals Ltd., Medicamen Biotech Ltd., Jiangxi Tianxin Pharmaceutical Co. Ltd., Koninklijke DSM N.V., and Emcure Pharmaceuticals Ltd. have implemented acquisition and expansion business strategies to increase their geographical presence. Few global players have invested in R&D amenities to discover advanced and innovative folic products with higher efficacy rate and ease of use.
Folic Acid Market Report Highlights:
- The food & beverages segment dominated the global folic acid market based on application, with a revenue share of 38.8% in 2024.
- The pharmaceuticals segment is also expected to experience the fastest CAGR from 2025 to 2030. Pharmaceutical formulations incorporating folic acid as the active ingredient are widely utilized in the treatment of patients exhibiting folate-deficient anemia.
- The offline segment held the largest revenue share of the folic acid market in 2024. A substantial proportion of end-users who incorporate folic acid into their product formulations exhibit a preference for offline procurement channels.
- The North America folic acid industry dominated the global market, with a revenue share of 32.8% in 2024. The region exhibits a high prevalence of folate-deficiency anemia, which has stimulated demand for fortified food products containing folic acid.
- The Asia Pacific folic acid market is anticipated to experience the fastest CAGR during the forecast period.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Folic Acid Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related Market Outlook
- 3.2. Industry Value Chain Analysis
- 3.3. Market Dynamics
- 3.3.1. Market Driver Analysis
- 3.3.2. Market Restraint Analysis
- 3.4. Industry Analysis Tools
- 3.4.1. Porter's Five Forces Analysis
- 3.5. Market Entry Strategies
Chapter 4. Folic Acid Market: Application Estimates & Trend Analysis
- 4.1. Folic Acid Market, By Application: Key Takeaways
- 4.2. Application Movement Analysis & Market Share, 2024 & 2030
- 4.3. Market Estimates & Forecasts, By Application, 2018 - 2030 (USD Million)
- 4.3.1. Food & Beverages
- 4.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.2. Pharmaceuticals
- 4.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.3. Nutraceuticals
- 4.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 4.3.4. Others
- 4.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 5. Folic Acid Market: Distribution Channel Estimates & Trend Analysis
- 5.1. Folic Acid Market, By Distribution Channel: Key Takeaways
- 5.2. Distribution Channel Movement Analysis & Market Share, 2024 & 2030
- 5.3. Market Estimates & Forecasts, by Distribution Channel, 2018 - 2030 (USD Million)
- 5.3.1. Offline
- 5.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 5.3.2. Online
- 5.3.2.1. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 6. Folic Acid Market: Regional Estimates & Trend Analysis
- 6.1. Folic Acid Market: Regional Outlook
- 6.2. Regional Marketplaces: Key Takeaways
- 6.3. Market Estimates & Forecasts, by Region, 2018 - 2030 (USD Million)
- 6.3.1. North America
- 6.3.1.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.1.2. U.S.
- 6.3.1.2.1. Key country dynamics
- 6.3.1.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.1.3. Canada
- 6.3.1.3.1. Key country dynamics
- 6.3.1.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.1.4. Mexico
- 6.3.1.4.1. Key country dynamics
- 6.3.1.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.2. Europe
- 6.3.2.1. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.3.2.2. U.K.
- 6.3.2.2.1. Key country dynamics
- 6.3.2.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.2.3. Germany
- 6.3.2.3.1. Key country dynamics
- 6.3.2.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.2.4. France
- 6.3.2.4.1. Key country dynamics
- 6.3.2.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.2.5. Italy
- 6.3.2.5.1. Key country dynamics
- 6.3.2.5.2. Market estimates and forecast, 2018 - 2030, (USD Million)
- 6.3.2.6. Spain
- 6.3.2.6.1. Key country dynamics
- 6.3.2.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3. Asia Pacific
- 6.3.3.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3.2. China
- 6.3.3.2.1. Key country dynamics
- 6.3.3.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3.3. India
- 6.3.3.3.1. Key country dynamics
- 6.3.3.3.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3.4. Japan
- 6.3.3.4.1. Key country dynamics
- 6.3.3.4.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3.5. Australia & New Zealand
- 6.3.3.5.1. Key country dynamics
- 6.3.3.5.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.3.6. South Korea
- 6.3.3.6.1. Key country dynamics
- 6.3.3.6.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.4. Central & South America
- 6.3.4.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.4.2. Argentina
- 6.3.4.2.1. Key country dynamics
- 6.3.4.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.5. Middle East & Africa
- 6.3.5.1. Market estimates and forecast, 2018 - 2030 (USD Million)
- 6.3.5.2. South Africa
- 6.3.5.2.1. Key country dynamics
- 6.3.5.2.2. Market estimates and forecast, 2018 - 2030 (USD Million)
Chapter 7. Folic Acid Market: Competitive Analysis
- 7.1. Recent Developments & Impact Analysis, by Key Market Participants
- 7.2. Company Categorization
- 7.3. Participant's Overview
- 7.4. Financial Performance
- 7.5. Application Benchmarking
- 7.6. Company Market Share Analysis, 2024 (%)
- 7.7. Company Heat Map Analysis
- 7.8. Strategy Mapping
- 7.9. Company Profiles
- 7.9.1. BASF SE
- 7.9.1.1. Company Overview
- 7.9.1.2. Financial Performance
- 7.9.1.3. Application Portfolios
- 7.9.1.4. Strategic Initiatives
- 7.9.2. Koninklijke DSM N.V.
- 7.9.2.1. Company Overview
- 7.9.2.2. Financial Performance
- 7.9.2.3. Application Portfolios
- 7.9.2.4. Strategic Initiatives
- 7.9.3. Zydus Pharmaceuticals Ltd.
- 7.9.3.1. Company Overview
- 7.9.3.2. Financial Performance
- 7.9.3.3. Application Portfolios
- 7.9.3.4. Strategic Initiatives
- 7.9.4. Medicamen Biotech Ltd.
- 7.9.4.1. Company Overview
- 7.9.4.2. Financial Performance
- 7.9.4.3. Application Portfolios
- 7.9.4.4. Strategic Initiatives
- 7.9.5. Emcure Pharmaceuticals Ltd.
- 7.9.5.1. Company Overview
- 7.9.5.2. Financial Performance
- 7.9.5.3. Application Portfolios
- 7.9.5.4. Strategic Initiatives
- 7.9.6. Jiangxi Tianxin Pharmaceutical Co. Ltd.
- 7.9.6.1. Company Overview
- 7.9.6.2. Financial Performance
- 7.9.6.3. Application Portfolios
- 7.9.6.4. Strategic Initiatives
- 7.9.7. Xinjiang Wujiaqu Xingnong Cycle Chemical Co. Ltd.
- 7.9.7.1. Company Overview
- 7.9.7.2. Financial Performance
- 7.9.7.3. Application Portfolios
- 7.9.7.4. Strategic Initiatives
- 7.9.8. Changzhou Niutang Chemical Plant Co. Ltd.
- 7.9.8.1. Company Overview
- 7.9.8.2. Financial Performance
- 7.9.8.3. Application Portfolios
- 7.9.8.4. Strategic Initiatives
- 7.9.9. Shandong Xinfa Pharmaceutical Co., Ltd.
- 7.9.9.1. Company Overview
- 7.9.9.2. Financial Performance
- 7.9.9.3. Application Portfolios
- 7.9.9.4. Strategic Initiatives
- 7.9.10. Hebei Jiheng Group Pharmacy Co Ltd.
- 7.9.10.1. Company Overview
- 7.9.10.2. Financial Performance
- 7.9.10.3. Application Portfolios
- 7.9.10.4. Strategic Initiatives